INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $49,000 | -40.2% | 1,967 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $82,000 | -12.8% | 1,967 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | -23.6% | 1,967 | +0.6% | 0.00% | -33.3% |
| Q1 2020 | $123,000 | -50.0% | 1,956 | -1.5% | 0.00% | -40.0% |
| Q4 2019 | $246,000 | +85.0% | 1,985 | -0.7% | 0.01% | +66.7% |
| Q3 2019 | $133,000 | -16.9% | 1,999 | -0.8% | 0.00% | -25.0% |
| Q2 2019 | $160,000 | -30.7% | 2,016 | -2.2% | 0.00% | -20.0% |
| Q1 2019 | $231,000 | – | 2,062 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $39,083,000 | 9.04% |
| Senvest Management, LLC | 1,152,032 | $70,873,000 | 5.40% |
| Melqart Asset Management (UK) Ltd | 298,200 | $18,345,000 | 2.20% |
| Elk Creek Partners, LLC | 348,454 | $21,437,000 | 1.25% |
| ALTRINSIC GLOBAL ADVISORS LLC | 375,223 | $23,084,000 | 0.93% |
| BB BIOTECH AG | 545,719 | $33,573,000 | 0.93% |
| Virtus ETF Advisers LLC | 14,681 | $903,000 | 0.78% |
| Opus Point Partners Management, LLC | 4,496 | $277,000 | 0.54% |
| Spark Investment Management LLC | 136,500 | $8,397,000 | 0.54% |
| Regal Investment Advisors LLC | 29,511 | $1,816,000 | 0.40% |